HRT vs antidepressants
what your doctor might not say.
A common pattern in primary care: a woman in her late 40s arrives with low mood, anxiety, irritability, insomnia. The doctor, working with a short visit and a training gap on menopause, prescribes an SSRI. Sometimes that’s the right call. Often it isn’t, because the symptoms started with cycle changes and the underlying issue is hormonal. Current menopause guidelines are explicit: antidepressants should NOT be offered as first-line for low mood arising for the first time in perimenopause, in women without a prior depressive disorder. HRT should be tried first. This article explains the pattern, the script, and when each option is actually right.
The pattern (and why it happens)
A 47-year-old woman walks into a doctor’s appointment. She’s tearful. She’s not sleeping. She snaps at her kids. She’s gained weight. Her periods are still happening, just irregularly. The doctor has a few minutes left, a depression screening tool that flags her positive, and a prescription pad. The fastest answer is sertraline.
The hormonal context, “these symptoms started two years ago when my cycles started shifting”, often doesn’t come up because it isn’t asked about. Antidepressants are prescribed in mid-life women at roughly twice the rate of men of the same age. A significant fraction of those prescriptions are written for what is, mechanistically, hormonally driven distress.
The reasons doctors default to SSRIs: very little menopause teaching in the average medical degree; lingering caution since the 2002 WHI study (the risk reporting from which has since been substantially revised); and a system that makes “trial of antidepressant” the path of least friction. None of this is the doctor being malicious. It’s a training and time-budget gap.
When SSRIs are the right call
- Pre-existing depression, long history of major depression independent of cycles or menopause; SSRIs are first-line.
- Severe depression with suicidal thoughts, HRT is not the first-line treatment for severe depression; antidepressants ± psychotherapy are.
- HRT contraindicated, past estrogen-receptor-positive breast cancer, active blood clotting disease without anticoagulation, certain liver conditions. Low-dose SSRIs/SNRIs are also effective for vasomotor symptoms in this group.
- HRT tried and inadequate, if mood symptoms persist after 3 months of optimised HRT, adding (or trying) an SSRI is reasonable.
When HRT is the better first try
- No prior history of depression and mood symptoms began with cycle changes, this is the textbook case for HRT first.
- Mood symptoms are part of a cluster, hot flushes, sleep problems, brain fog, low libido, irregular periods, treating the underlying hormonal driver often addresses all of them at once.
- PMDD history, postnatal depression history, severe PMS, these point to estrogen-fluctuation sensitivity. HRT often helps more than an SSRI here.
- Early menopause / POI, HRT is replacement, not optional, and protects bone, brain and cardiovascular health.
Trials of HRT for perimenopausal mood disorders consistently show meaningful improvement, including studies of transdermal estradiol 100 µg with intermittent micronized progesterone showing reduced depression scores at 12 months. This is not fringe science; it’s in the consensus statements of The Menopause Society and leading clinical guidelines.
The script, how to ask
You don’t have to fight your doctor. You have to give them the information they need to make the right call quickly. Something like:
Bring a symptom timeline (when did each thing start; how does it relate to cycles if you still have them) and a one-page list of the symptoms. The Decodemeno report includes both, that’s the part designed for the appointment.
If your doctor won’t engage, ask to be referred to a colleague with a menopause interest, or book a single consultation with a certified menopause specialist. Many will write to your primary care doctor recommending the regimen, which your doctor can then prescribe.
What if both are appropriate?
Plenty of women end up on both, particularly if there’s a depressive vulnerability that the menopause has pushed over the line. There’s no evidence-based prohibition against combining HRT with an SSRI/SNRI. One caveat: avoid paroxetine if you’re on tamoxifen for breast cancer (it interferes with tamoxifen activation). Bupropion (Wellbutrin) is often preferred over standard SSRIs in mid-life for its lower libido and weight side effects.
Tapering an antidepressant if HRT works
If you started an SSRI in error and HRT subsequently does the job, do not stop the antidepressant abruptly. SSRI/SNRI withdrawal can be severe and prolonged, particularly with venlafaxine and paroxetine. Talk to your doctor about a slow taper, usually over months. The Royal College of Psychiatrists has published current guidance on hyperbolic tapering that many doctors aren’t familiar with by default, print the patient leaflet and bring it.
- Current menopause guidelines on mood disorders: antidepressants are NOT first-line for new low mood in perimenopause.
- The Menopause Society, clinician tools, mood & mental health.
- Gordon JL et al., “Transdermal estradiol and progesterone for prevention of depressive symptoms in the menopause transition”, JAMA Psychiatry 2018.
- Schmidt PJ et al., estrogen for perimenopausal depression, multiple trials, NIH.
- Royal College of Psychiatrists, Stopping antidepressants patient guidance (2024).
- Bluming & Tavris, Estrogen Matters, WHI re-analysis and clinical implications.
Walk into your next doctor appointment prepared.
Take the 5-minute quiz →Educational only. Not medical advice. Never stop a prescribed antidepressant abruptly; always work with your doctor or psychiatrist on tapering.